Publication | Open Access

Phase 2 Study of Temozolomide-Based Chemoradiation Therapy for High-Risk Low-Grade Gliomas: Preliminary Results of Radiation Therapy Oncology Group 0424

Neuro-oncologyRadiation MedicineRadiation TherapyGliomaMedicineHigh-grade GliomasCancer TreatmentPhase 2High-risk Low-grade GliomasOncologyRadiation OncologyTemozolomide-based Chemoradiation TherapyRadiologyHealth Sciences